Valuation: Biogen Inc.

Market Cap 28.34B 24.78B 22.86B 21.01B 39.81B 2,727B 40.49B 273B 107B 1,333B 106B 104B 4,594B P/E 2026 *
22.8x
P/E 2027 * 15.4x
Enterprise Value 33.91B 29.65B 27.35B 25.14B 47.64B 3,263B 48.45B 327B 128B 1,595B 127B 125B 5,497B EV / Sales 2026 *
3.36x
EV / Sales 2027 * 3.07x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day+2.88%
1 week-1.02%
Current month-8.22%
1 month-0.17%
3 months+9.84%
6 months+17.64%
Current year+12.68%
1 week 186.02
Extreme 186.025
210.87
1 month 186.02
Extreme 186.025
219.72
Current year 160.36
Extreme 160.3645
219.72
1 year 121.05
Extreme 121.05
219.72
3 years 110.04
Extreme 110.035
281.12
5 years 110.04
Extreme 110.035
351.86
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
09/06Free

Director

1,505 0.0010%
09/06Free

Chairman

2,005 0.0014%
09/06Fiscal year

Director

6,245 0.0042%
Change 5-day change 1-year change 3-year change Capi.($)
+2.88%-1.02%+55.54%-28.77% 28.34B
+1.06%+0.16%+21.16%-8.00% 66.75B
+1.38%-5.23%+38.08%+194.04% 50.65B
+1.10%+38.30%+38.30%+38.30% 42.55B
-0.98%-1.79%-49.61%-53.35% 41.15B
+0.99%-7.93%+115.17%-44.58% 26.76B
-0.25%-2.17%+68.09%+87.82% 22.95B
+7.77%+11.30%+18.35%+199.08% 20B
-1.37%+5.84%+76.53%+158.75% 16.48B
+0.44%-3.68%+55.00%+121.57% 16.3B
Average +1.30%-2.68%+43.66%+66.49% 33.19B
Weighted average by Cap. +1.17%-3.09%+35.17%+52.17%

Financials

2026 *2027 *
Net sales 10.09B 8.82B 8.14B 7.48B 14.18B 971B 14.42B 97.16B 38.12B 475B 37.9B 37.06B 1,636B 10.36B 9.06B 8.36B 7.68B 14.56B 997B 14.8B 99.77B 39.15B 487B 38.91B 38.06B 1,680B
Net income 1.36B 1.19B 1.1B 1.01B 1.91B 131B 1.95B 13.12B 5.15B 64.06B 5.12B 5B 221B 1.95B 1.7B 1.57B 1.44B 2.74B 188B 2.78B 18.77B 7.36B 91.66B 7.32B 7.16B 316B
Net Debt 5.57B 4.87B 4.49B 4.13B 7.83B 536B 7.96B 53.65B 21.05B 262B 20.92B 20.47B 903B 3.44B 3B 2.77B 2.55B 4.83B 331B 4.91B 33.09B 12.99B 162B 12.91B 12.62B 557B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
16/07/26 USD 197.24 +2.76% 2,067,235
14/07/26 USD 191.95 -8.17% 3,902,309
13/07/26 USD 209.03 +4.96% 2,259,821
10/07/26 USD 199.15 +0.12% 1,133,120
09/07/26 USD 198.91 -0.72% 1,657,327
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
191.95USD
Average target price
225.45USD
Spread / Average Target
+17.45%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock